MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
bigg.metabolite:CE5797 biggM:CE5797 NSLIVCMCAULZET-WFJLUAAKSA-N | Neuromedin N |
| hmdb:HMDB0013022 NSLIVCMCAULZET-WFJLUAAKSA-N | Neuromedin N (2S)-2-[(2R,3R)-2-[(2S)-2-{[(2S)-1-[(2R,3R)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid (2S)-2-{[(2R,3R)-2-{[(2S)-2-({[(2S)-1-[(2R,3R)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-4-methylpentanoate NN |
vmhM:CE5797 vmhmetabolite:CE5797 NSLIVCMCAULZET-WFJLUAAKSA-N | neuromedin N (2S)-2-[(2R,3R)-2-[(2S)-2-{[(2S)-1-[(2R,3R)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid |
hmdb:HMDB13022 biggM:M_CE5797 vmhM:M_CE5797 | secondary/obsolete/fantasy identifier |